Profil
Barrie J.
Carter is currently the Director at the American Society of Gene Therapy and a Member-Advisory Committee at the University of Washington.
Previously, he held positions as the Director at Opus Bio, Inc., Chief Scientific Officer & Executive VP at AmpliPhi Biosciences Corp.
from 1992 to 2008, Vice President-Vector Biology at BioMarin Pharmaceutical, Inc. from 2013 to 2018, Principal at the National Institutes of Health in 1992, Principal at the National Institute of Diabetes & Digestive & Kidney Diseases from 1982 to 1992, and was a Member-Advisory Board at Keystone Symposia.
Dr. Carter obtained his undergraduate degree from the University of Otago in 1996 and his doctorate degree from the same university in 1969.
Postes actifs de Barrie J. Carter
| Sociétés | Poste | Début |
|---|---|---|
American Society of Gene Therapy | Directeur/Membre du Conseil | - |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2000 |
Anciens postes connus de Barrie J. Carter
| Sociétés | Poste | Fin |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/12/2018 |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Directeur Technique/Scientifique/R&D | 06/11/2008 |
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Corporate Officer/Principal | 01/01/1992 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 01/01/1992 |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Operates nonprofit organization that convenes open, peer-reviewed conferences across a broad range of the life sciences | Directeur/Membre du Conseil | 31/10/2011 |
Formation de Barrie J. Carter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology Develops and commercializes novel bacteriophage-based therapeutics | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Otago
University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
National Institute of Diabetes & Digestive & Kidney Diseases
National Institute of Diabetes & Digestive & Kidney Diseases General GovernmentGovernment Engages in clinical research on serious diseases | Government |
Opus Bio, Inc.
Opus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and manufactures lentiviral gene delivery technologies | Commercial Services |
Keystone Symposia
Keystone Symposia Miscellaneous Commercial ServicesCommercial Services Operates nonprofit organization that convenes open, peer-reviewed conferences across a broad range of the life sciences | Commercial Services |
American Society of Gene Therapy |
















